Catalog No.
RHC43401
Species reactivity
Human, Mouse
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
IHC: 1:200-1:1000, WB: 1:500-1:2000
Target
p55-Fgr, Tyrosine-protein kinase Fgr, p58-Fgr, p58c-Fgr, SRC2, Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog, FGR, Proto-oncogene c-Fgr
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P09769
Applications
IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3B75
Hydroxychloroquine can reduce fetal growth restriction in a dexamethasone-induced rat model., PMID:40339230
Transcriptomic signatures in peripheral CD4+T-lymphocytes may reflect melanoma staging and immunotherapy responsiveness prior to ICI initiation., PMID:40226614
Antiphospholipid syndrome in pregnancy: a comprehensive literature review., PMID:40128683
Inhibition of Kinase Activity and In Vitro Downregulation of the Protein Kinases in Lung Cancer and Cervical Cancer Cell Lines and the Identified Known Anticancer Compounds of Ziziphus mucronata., PMID:39942957
Efficacy of combining aspirin with hydroxychloroquine in pregnancies at high risk for pre-eclampsia: a prospective, multicentre, open-label, single-arm clinical trial, investigator-initiated study (HUGS study)., PMID:39658277
Perinatal outcomes in indian women with Antiphospholipid Antibody Syndrome (APS): Five year experience from a tertiary care centre., PMID:39296875
[Screening and validation of therapeutic targets for chronic sinusitis with nasal polyps based on proteomics]., PMID:39107122
Criteria and non-criteria antiphospholipid autoantibodies screening in patients with late pregnancy morbidity: A cross-sectional study., PMID:38959700
Correlation of Anti-Phosphatidylserine/Prothrombin and Anti-Phosphatidylserine Antibodies with Pregnancy Outcomes., PMID:38958240
Modern Management of Pregnancy in Systemic Lupus Erythematosus: From Prenatal Counseling to Postpartum Support., PMID:38929983
[Analysis of adverse neonatal outcomes in pregnant women with positive anti-Ro/SSA and anti-La/SSB antibodies]., PMID:37981765
[Association of maternal isolated thyroid peroxidase antibody positive in the first trimester with fetal growth]., PMID:37807744
Preeclampsia and the Antiphospholipid Syndrome., PMID:37626793
Establishment and Characterization of Mild Atopic Dermatitis in the DNCB-Induced Mouse Model., PMID:37569701
Placental pathology in early-onset fetal growth restriction: insights into fetal growth restriction mechanisms., PMID:37518879
Anti-β2-glycoprotein I/HLA-DR Antibody and Adverse Obstetric Outcomes., PMID:37446134
Retrospective immunohistochemical analysis of human cytomegalovirus infection in the placenta and its association with fetal growth restriction., PMID:37234388
Effect of levothyroxine treatment on fetal growth among women with mild subclinical hypothyroidism and thyroid peroxidase antibody negative: a cohort study., PMID:37202755
Analysis of intracellular tyrosine phosphorylation in circulating neutrophils as a rapid assay for the in vivo effect of oral tyrosine kinase inhibitors., PMID:37089957
Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group., PMID:37028222
Maternal Cold-Reacting Immunoglobulin G Anti-M of MNS Blood Group System Causing Hemolytic Disease of the Fetus., PMID:36934323
An advanced understanding of the heterogeneous clinical features of "non-criteria" obstetric antiphospholipid syndrome: Two case reports and a literature review., PMID:36865564
Placental T-Cadherin Correlates With Trophoblastic Invasion Anomalies: Placenta Percreta and Fetal Growth Restriction., PMID:36731049
Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy., PMID:36717307
Immunosuppressive therapy before and during pregnancy may improve obstetric outcomes in pregnancy complicated by dermatomyositis with anti-MDA-5 antibody positivity: A case report., PMID:36683783
Analysis of the relationship between placental histopathological aspects of preterm and term birth., PMID:36374141
Effects of perinatal disease activity on offspring's growth in patients with systemic lupus erythematosus., PMID:39439694
Inhibition of the AT1R agonistic autoantibody in a rat model of preeclampsia improves fetal growth in late gestation., PMID:36121142
Society for Maternal-Fetal Medicine Consult Series #64: Systemic lupus erythematosus in pregnancy., PMID:36084704
Placental damage in pregnancies with systemic lupus erythematosus: A narrative review., PMID:36059466
Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis., PMID:35685559
Long-term monitoring of blood biomarkers related to intrauterine growth restriction using AgNPs SERS tags-based lateral flow assay., PMID:35038640
TNFα blockade reverses vascular and uteroplacental matrix metalloproteinases imbalance and collagen accumulation in hypertensive pregnant rats., PMID:34600915
Maternal and Perinatal Outcomes of Pregnancy in Women With Autoimmune Disorder., PMID:34336512
Placental pathologic features in thyroid autoimmunity., PMID:34304015
Central 22q11.2 deletion (LCR22 B-D) in a fetus with severe fetal growth restriction and a mother with severe systemic lupus erythematosus: Further evidence of CRKL haploinsufficiency in the pathogenesis of 22q11.2 deletion syndrome., PMID:34196458
Individualized growth assessment in pregnancies complicated by fetal gastroschisis., PMID:34098833
Fetal Growth and Stillbirth., PMID:33972067
Aspirin Desensitization: Implications for Acetylsalicylic Acid-Sensitive Pregnant Women., PMID:33920569
Risk factors for pregnancy morbidity in women with antiphospholipid syndrome., PMID:33845396
Morphological and histopathological changes in placentas of pregnancies with intrauterine growth restriction., PMID:33544799
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory Phenotype., PMID:33203088
Abnormal placental CD8+ T-cell infiltration is a feature of fetal growth restriction and pre-eclampsia., PMID:32886802
Non-invasive prediction of fetal growth restriction by whole-genome promoter profiling of maternal plasma DNA: a nested case-control study., PMID:32364311
Whole-Genome Promoter Profiling of Plasma DNA Exhibits Diagnostic Value for Placenta-Origin Pregnancy Complications., PMID:32274292
Pathomorphological characteristics and immunohistochemical features of placentae from hiv-positive pregnant women with fetal growth retardation., PMID:32248147
Pregnancy Management in Women with Antiphospholidic Syndrome., PMID:31523297
Prediction of Adverse Pregnancy Outcomes in Women with Systemic Lupus Erythematosus., PMID:31444781
The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 1000 consecutive cases., PMID:30772493
Prospective Cohort Study of Congenital Cytomegalovirus Infection during Pregnancy with Fetal Growth Restriction: Serologic Analysis and Placental Pathology., PMID:30413316
For research use only. Not for human or drug use.
